Fig. 6

Potential biomarkers changes in DOX-induced CHF with HG/[6]-GR treatment. a Acetylphosphate; b LysoPC(18:1(9Z)); c Oleic acid; d Coenzyme A; e 3-Carboxy-1-hydroxypropylthiamine diphosphate; f PC(16:0/16:0); g PE(O-18:1(1Z)/20:4(5Z,8Z,11Z,14Z)); h Palmitic acid. Compared with the control group, **P < 0.01; compared with the DOX group, ^#P < 0.05, ^##P < 0.01; compared with the HG group, ^aP < 0.05, ^aaP < 0.01; compared with the [6]-GR group, ^bbP < 0.01